Study results indicate that patients treated with Vertos Medical’s mild® procedure for lumbar spinal stenosis showed a change in functional improvement at one year. Treated patients were also able to walk 250% longer than before the procedure.
These one-year results are consistent with those of the prior Level 1 study, and add to the body of evidence demonstrating that the mild Procedure can provide mobility improvement along with quality-of-life improvements for patients.
Additional 1-year data for patients receiving the mild® Procedure plus CMM vs CMM alone include:
250% improvement in walking time compared to baseline prior to the procedure
0% device- or procedure-related adverse or serious adverse events
Less than 8% of mild patients required a subsequent intervention
The mild procedure removes a major root cause of stenosis through a portal the size of a baby aspirin and requires no implants, no general anesthesia, no stitches and no overnight hospital stay.
MOTION is a prospective, randomized controlled study, designed to evaluate functional improvement for patients treated with the mild procedure as first-line therapy in a real-world setting. In the study, patients were treated with the mild® Procedure plus CMM or CMM alone, reflecting real-world treatment progression and patient care. The study enrolled 155 patients who were 50-80 years of age from 19 sites across the United States. It is the second largest, multi-center, randomized controlled study that has been done on the mild procedure.
Study results indicate that patients treated with Vertos Medical's mild® procedure for lumbar spinal stenosis showed a change in functional improvement at one year. Treated patients were also able to walk 250% longer than before the procedure.
These one-year results are consistent with those of the prior Level 1 study, and add to the body of...
Study results indicate that patients treated with Vertos Medical’s mild® procedure for lumbar spinal stenosis showed a change in functional improvement at one year. Treated patients were also able to walk 250% longer than before the procedure.
These one-year results are consistent with those of the prior Level 1 study, and add to the body of evidence demonstrating that the mild Procedure can provide mobility improvement along with quality-of-life improvements for patients.
Additional 1-year data for patients receiving the mild® Procedure plus CMM vs CMM alone include:
250% improvement in walking time compared to baseline prior to the procedure
0% device- or procedure-related adverse or serious adverse events
Less than 8% of mild patients required a subsequent intervention
The mild procedure removes a major root cause of stenosis through a portal the size of a baby aspirin and requires no implants, no general anesthesia, no stitches and no overnight hospital stay.
MOTION is a prospective, randomized controlled study, designed to evaluate functional improvement for patients treated with the mild procedure as first-line therapy in a real-world setting. In the study, patients were treated with the mild® Procedure plus CMM or CMM alone, reflecting real-world treatment progression and patient care. The study enrolled 155 patients who were 50-80 years of age from 19 sites across the United States. It is the second largest, multi-center, randomized controlled study that has been done on the mild procedure.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
